Yongfei Wang

Author PubWeight™ 270.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009 11.51
2 Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006 8.18
3 Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 2013 8.08
4 An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008 6.00
5 The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005 5.86
6 Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002 5.74
7 Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes 2009 5.66
8 An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 2006 5.35
9 Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003 5.09
10 Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA 2006 5.06
11 An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 2006 4.52
12 Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation 2006 4.35
13 Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009 4.29
14 Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004 4.14
15 Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006 4.11
16 Evaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality data. JAMA 2002 4.06
17 Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2009 3.95
18 Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005 3.78
19 Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 2005 3.46
20 Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA 2004 3.45
21 Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008 3.42
22 Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004 3.37
23 Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med 2012 2.86
24 Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. Arch Intern Med 2009 2.80
25 Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA 2003 2.77
26 Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005 2.69
27 Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ 2009 2.55
28 National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 2004 2.46
29 Patterns of weight change preceding hospitalization for heart failure. Circulation 2007 2.45
30 Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 2006 2.40
31 All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol 2009 2.40
32 The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 2003 2.34
33 National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes 2010 2.33
34 Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol 2010 2.26
35 The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. J Hosp Med 2010 2.20
36 Use of medical imaging procedures with ionizing radiation in children: a population-based study. Arch Pediatr Adolesc Med 2011 2.12
37 Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol 2010 2.07
38 Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 2003 1.89
39 The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2010 1.87
40 Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2011 1.85
41 Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 2005 1.83
42 Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation 2011 1.82
43 Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction. J Gen Intern Med 2006 1.82
44 Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation 2006 1.78
45 Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010 1.74
46 Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction. Med Care 2005 1.73
47 Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes 2013 1.72
48 Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 2006 1.69
49 Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol 2005 1.69
50 Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation 2007 1.61
51 Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes. Circulation 2006 1.61
52 Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009 1.60
53 Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med 2008 1.59
54 Nonsteroidal antiinflammatory drugs after acute myocardial infarction. Am Heart J 2002 1.58
55 National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol 2009 1.57
56 Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Arch Intern Med 2011 1.54
57 Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 2005 1.54
58 Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA 2013 1.51
59 Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 2011 1.49
60 Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 2009 1.46
61 Physician specialty and mortality among elderly patients hospitalized with heart failure. Am J Med 2005 1.45
62 Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®). Catheter Cardiovasc Interv 2013 1.43
63 Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®. Pacing Clin Electrophysiol 2012 1.40
64 Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2009 1.40
65 Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™. J Cardiovasc Electrophysiol 2012 1.39
66 The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm 2013 1.39
67 Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 2008 1.38
68 Review of the registry's first year, data collected, and future plans. Heart Rhythm 2007 1.35
69 Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes. Circ Cardiovasc Qual Outcomes 2010 1.35
70 Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm 2008 1.32
71 The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med 2005 1.32
72 Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness. Ann Intern Med 2002 1.31
73 Variation in hospital mortality rates for patients with acute myocardial infarction. Am J Cardiol 2010 1.28
74 National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol 2013 1.27
75 Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med 2012 1.24
76 The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4. J Am Coll Cardiol 2006 1.24
77 Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation 2005 1.24
78 Quality of care for acute myocardial infarction at urban safety-net hospitals. Health Aff (Millwood) 2007 1.23
79 Income inequality and 30 day outcomes after acute myocardial infarction, heart failure, and pneumonia: retrospective cohort study. BMJ 2013 1.23
80 Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009 1.22
81 Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). Am Heart J 2006 1.21
82 Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol 2008 1.19
83 Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation 2009 1.19
84 A high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study, 2002 to 2010. JAMA Intern Med 2013 1.19
85 Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. J Am Coll Cardiol 2010 1.18
86 Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes 2012 1.17
87 Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA 2003 1.15
88 Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. J Am Coll Cardiol 2008 1.14
89 Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. J Invasive Cardiol 2012 1.13
90 The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail 2010 1.12
91 Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Med Care 2004 1.10
92 The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer 2012 1.09
93 Recent trends in hospitalization for acute myocardial infarction. Am J Cardiol 2012 1.08
94 Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med 2005 1.05
95 Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. Pacing Clin Electrophysiol 2013 1.05
96 National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction, heart failure, and pneumonia: update on publicly reported outcomes measures based on the 2013 release. J Gen Intern Med 2014 1.04
97 Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis. Circulation 2006 1.04
98 Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction. Am J Med 2008 1.04
99 Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care 2005 1.02
100 Diagnosis and minimally invasive surgery for the pituitary abscess: a review of twenty nine cases. Clin Neurol Neurosurg 2012 1.02
101 Quality of care of Medicare beneficiaries with acute myocardial infarction: who is included in quality improvement measurement? J Am Geriatr Soc 2003 1.02
102 Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data Registry. J Am Coll Cardiol 2007 1.01
103 Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 2010 1.01
104 Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes 2011 0.98
105 Mental disorders, quality of care, and outcomes among older patients hospitalized with heart failure: an analysis of the national heart failure project. Arch Gen Psychiatry 2008 0.97
106 Physician procedure volume and complications of cardioverter-defibrillator implantation. Circulation 2011 0.95
107 Hospital-based, acute care use among patients within 30 days of discharge after coronary artery bypass surgery. Ann Thorac Surg 2013 0.94
108 Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study. Endocr J 2010 0.93
109 Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2007 0.92
110 Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. J Am Coll Cardiol 2010 0.92
111 Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry. Am Heart J 2013 0.92
112 Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study. BMJ 2003 0.91
113 DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma. Endocr Relat Cancer 2013 0.91
114 Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction. Circulation 2007 0.90
115 Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study. Circulation 2013 0.90
116 Correlations among risk-standardized mortality rates and among risk-standardized readmission rates within hospitals. J Hosp Med 2012 0.90
117 What are hospitals doing to increase beta-blocker use? Jt Comm J Qual Saf 2003 0.87
118 The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. J Card Fail 2004 0.86
119 Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Am Heart J 2009 0.86
120 The door-to-balloon alliance for quality: who joins national collaborative efforts and why? Jt Comm J Qual Patient Saf 2009 0.86
121 Regional density of cardiologists and rates of mortality for acute myocardial infarction and heart failure. Circ Cardiovasc Qual Outcomes 2013 0.85
122 Lower hospital volume is associated with higher in-hospital mortality in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction: A report from the NCDR. Circ Cardiovasc Qual Outcomes 2013 0.84
123 Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 2005 0.84
124 Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry. J Am Heart Assoc 2012 0.84
125 US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas. Health Aff (Millwood) 2011 0.83
126 Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures. Am Heart J 2010 0.83
127 Genome-wide identification of heat shock proteins (Hsps) and Hsp interactors in rice: Hsp70s as a case study. BMC Genomics 2014 0.82
128 Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry. J Am Coll Cardiol 2012 0.81
129 Prior aspirin use and outcomes in elderly patients hospitalized with acute myocardial infarction. J Am Coll Cardiol 2005 0.81
130 Evaluation of protein phosphorylation site predictors. Protein Pept Lett 2010 0.81
131 Predictors of cardiologist care for older patients hospitalized for heart failure. Am Heart J 2004 0.80
132 Immuno-laser capture microdissection of frozen prolactioma sections to prepare proteomic samples. Colloids Surf B Biointerfaces 2009 0.80
133 Contemporary evidence: baseline data from the D2B Alliance. BMC Res Notes 2008 0.79
134 Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry). Am J Cardiol 2012 0.79
135 Determinants of cardiac catheterization use in older Medicare patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2009 0.79
136 Effective performance of contrast enhanced SPACE imaging in clearly depicting the margin of pituitary adenoma. Pituitary 2015 0.79
137 Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses. Alcohol Clin Exp Res 2006 0.78
138 Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals. J Am Geriatr Soc 2011 0.78
139 The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegaly. Endocr J 2016 0.78
140 Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry. Circulation 2013 0.78
141 Admission body temperature and mortality in elderly patients hospitalized for heart failure. J Am Coll Cardiol 2006 0.77
142 Regional associations between Medicare Advantage penetration and administrative claims-based measures of hospital outcomes. Med Care 2012 0.77
143 [Expression of CCDC67 mRNA and its role in patients with papillary thyroid carcinoma]. Zhonghua Yi Xue Za Zhi 2014 0.77
144 Development of a Hospital Outcome Measure Intended for Use With Electronic Health Records: 30-Day Risk-standardized Mortality After Acute Myocardial Infarction. Med Care 2015 0.77
145 NBD-based fluorescent chemosensor for the selective quantification of copper and sulfide in an aqueous solution and living cells. Org Biomol Chem 2015 0.77
146 Improvements in the distribution of hospital performance for the care of patients with acute myocardial infarction, heart failure, and pneumonia, 2006-2011. Med Care 2015 0.76
147 Systolic function as a predictor of mortality and quality of life in long-term survivors with heart failure. Clin Cardiol 2008 0.76
148 Recovery of HPA Axis Function After Successful Gonadotropin-Induced Pregnancy and Delivery in a Woman With Panhypopituitarism: Case Report and Review. Medicine (Baltimore) 2015 0.75
149 A systematic review and meta-analysis of surgeries performed for treating deep-seated cerebral cavernous malformations. Br J Neurosurg 2015 0.75
150 Long-term storage and subsequent reactivation of aerobic granules. Bioresour Technol 2008 0.75
151 Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation. Circ Cardiovasc Qual Outcomes 2011 0.75
152 Retinal nerve fiber layer changes after transsphenoidal and transcranial pituitary adenoma resection. Pituitary 2016 0.75
153 Understanding the use and impact of the online community in a national quality improvement campaign. BMJ Qual Saf 2011 0.75
154 Person reidentification by minimum classification error-based KISS metric learning. IEEE Trans Cybern 2014 0.75
155 [Improved lipid productivity of Nannochloropsis by heavy-ion irradiation mutagenesis]. Sheng Wu Gong Cheng Xue Bao 2013 0.75
156 Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients. Circ Cardiovasc Qual Outcomes 2012 0.75
157 Gene expression profiling in human null cell pituitary adenoma tissue. Pituitary 2007 0.75
158 Comparison of multifocal visual evoked potential, static automated perimetry, and optical coherence tomography findings for assessing visual pathways in patients with pituitary adenomas. Pituitary 2015 0.75
159 [One case of bilateral chylothorax after cervical lymph node dissection in thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014 0.75